Rising stars
Lexplore
The eye movement of a child reading may indicate an increased risk of dyslexia or reading difficulties. This discovery led to the formation of the company Lexplore that today has operations in Sweden, the UK and the US. Now, the researchers behind the breakthrough are adapting the technology to identify early Alzheimer’s and Parkinson’s.
Oncopeptides
Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.
Chundsell Medical
He is behind a unique test to distinguish benign prostate cancer from aggressive forms of the condition that require immediate treatment. Finding the right contacts at the right time was key to the success of the project.
Heartrunner Sweden
In Sweden, there are currently some 21,000 volunteers ready to respond to help cardiac arrest victims. A smartphone alert system guides them directly to victims – often faster than ambulances. The service, the result of research carried out at the Centrum för Hjärtstoppsforskning, is now ready for export markets.
Extroducer
Staffan Holmin has developed a microcatheter that delivers drugs and cells directly to the body’s organs via blood vessels. The next step is to take samples from organs that are hard or too risky to reach with other methods. The key to success is an interdisciplinary team with a variety of core skill sets.
Curosurf
The Curosurf story is a tale of success. To date, the drug has saved the lives of around one million premature babies worldwide. And the story is far from over. Despite being 73, Tore Curstedt returns to the lab every day - the lab where he has developed a new variant of a drug that is set to help many more babies in the future.
